Your browser doesn't support javascript.
loading
An international, randomized, placebo-controlled, phase 2b clinical trial of intepirdine for dementia with Lewy bodies (HEADWAY-DLB).
Lang, Frederick M; Kwon, Daniel Y; Aarsland, Dag; Boeve, Brad; Tousi, Babak; Harnett, Mark; Mo, Yi; Noel Sabbagh, Marwan.
Afiliación
  • Lang FM; Axovant Sciences New York New York USA.
  • Kwon DY; Roivant Sciences Inc. (Roivant) New York New York USA.
  • Aarsland D; Axovant Sciences New York New York USA.
  • Boeve B; Roivant Sciences Inc. (Roivant) New York New York USA.
  • Tousi B; Centre for Age-Related Medicine (SESAM) Stavanger University Hospital Stavanger Norway.
  • Harnett M; Institute of Psychiatry Psychology and Neuroscience King's College London London UK.
  • Mo Y; Department of Neurology Mayo Clinic Rochester Minnesota USA.
  • Noel Sabbagh M; Cleveland Clinic Lou Ruvo Center for Brain Health Cleveland Ohio USA.
Alzheimers Dement (N Y) ; 7(1): e12171, 2021.
Article en En | MEDLINE | ID: mdl-34189249
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Alzheimers Dement (N Y) Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Alzheimers Dement (N Y) Año: 2021 Tipo del documento: Article